Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells
Title | Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Kulkarni-Dwivedi, N, Patel, PR, V. Shravage, B, Umrani, RD, Paknikar, KM, Jadhav, SH |
Journal | Nanomedicine |
Volume | 17 |
Issue | 25 |
Pagination | 1929-1949 |
Date Published | OCT |
Type of Article | Article |
ISSN | 1743-5889 |
Keywords | Apoptosis, Autophagy, Breast cancer, combination therapy, doxorubicin, Folic acid, hyperthermia, LSMO, MDA-MB231 cells, PEG |
Abstract | Background: Studies on the anticancer effects of lanthanum strontium manganese oxide (LSMO) nanoparticles (NPs)-mediated hyperthermia at cellular and molecular levels are scarce. Materials & methods: LSMO NPs conjugated with folic acid (Fol-LSMO NPs) were synthesized, followed by doxorubicin-loading (DoxFol-LSMO NPs), and their effects on breast cancer cells were investigated. Results: Hyperthermia (45 degrees C) and combination treatments exhibited the highest (similar to 95%) anticancer activity with increased oxidative stress. The involvement of intrinsic mitochondria-mediated apoptotic pathway and induction of autophagy was noted. Cellular and molecular evidence confirmed the crosstalk between apoptosis and autophagy, involving Beclin1, Bcl2 and Caspase-3 genes with free reactive oxygen species presence. Conclusion: The study confirmed hyperthermia and doxorubicin release by Fol-LSMO NPs induces apoptosis and autophagy in breast cancer cells. |
DOI | 10.2217/nnm-2022-0171 |
Type of Journal (Indian or Foreign) | Foreign |
Impact Factor (IF) | 6.096 |
Add new comment